The first SOHO Asia will launch in January 2026 and will be held in Taipei, Taiwan. The meeting will be held from January 23–25, 2026, and will feature speakers from all over the world, including Taiwan, Singapore, Japan, Korea, Hong Kong, and the United States. The two-day meeting will cover all of blood cancers with world-leading hematology experts presenting sessions. To register for SOHO Asia, visit sohoasia2026.org.
Among the faculty in attendance will be 2025–2026 SOHO President John DiPersio, MD, PhD. Dr. DiPersio also sits on the SOHO Asia Organizing Committee. Read Dr. DiPersio’s welcome letter below.
Dear colleagues and friends,
It is my great pleasure to welcome you to the SOHO Asia 2026 Annual Meeting, which will be held in Taipei, Taiwan, at the Evergreen International Convention Center.
We are entering an exciting era in the treatment of hematologic malignancies. From targeted therapies and immunotherapy to cellular therapies, the global medical and research communities are redefining standards of care and improving patient outcomes.
SOHO Asia 2026 will focus on the latest advances in leukemia, lymphoma, multiple myeloma, and myeloproliferative neoplasms, featuring leading experts from across Asia and around the world. Through the sharing of cutting-edge research and real-world clinical experiences, this meeting aims to promote scientific exchange and strengthen collaboration across borders.
We believe that this event will serve not only as a platform for knowledge sharing but also as a bridge for building lasting partnerships in the fight against blood cancers.
We look forward to welcoming you to Taipei in 2026 – a vibrant city blending tradition and innovation – and to exploring the future of hematologic oncology together.
Register now at https://www.sohoasia2026.org/.
Warm regards,
Dr. John DiPersio, President of SOHO
